• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续左旋多巴输注治疗帕金森病复杂肌张力障碍。

Continuous levodopa infusions to treat complex dystonia in Parkinson's disease.

作者信息

Sage J I, McHale D M, Sonsalla P, Vitagliano D, Heikkila R E

机构信息

Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick.

出版信息

Neurology. 1989 Jul;39(7):888-91. doi: 10.1212/wnl.39.7.888.

DOI:10.1212/wnl.39.7.888
PMID:2472582
Abstract

We report the clinical spectrum of 3 patients with Parkinson's disease who experienced complex patterns of levodopa-related dystonia. Dystonia was unrelieved by multiple medication regimens but responded well to continuous, duodenal levodopa infusions. Patients were able to remain mobile without severe dystonia despite a very narrow window of benefit between the levodopa concentration necessary to achieve the "on" state and that which caused the onset of dystonic spasms.

摘要

我们报告了3例帕金森病患者的临床情况,这些患者经历了复杂的左旋多巴相关肌张力障碍模式。多种药物治疗方案均无法缓解肌张力障碍,但持续十二指肠左旋多巴输注对此反应良好。尽管在达到“开”状态所需的左旋多巴浓度与引发肌张力障碍性痉挛的浓度之间存在非常狭窄的获益窗口,但患者仍能在无严重肌张力障碍的情况下保持活动能力。

相似文献

1
Continuous levodopa infusions to treat complex dystonia in Parkinson's disease.持续左旋多巴输注治疗帕金森病复杂肌张力障碍。
Neurology. 1989 Jul;39(7):888-91. doi: 10.1212/wnl.39.7.888.
2
End-of-dose dystonia in Parkinson's disease.
Neurology. 1993 Oct;43(10):2130-1. doi: 10.1212/wnl.43.10.2130.
3
Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.左旋多巴持续十二指肠输注:帕金森病患者的血浆浓度与运动波动
Clin Neuropharmacol. 1988 Feb;11(1):36-44.
4
Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.十二指肠输注左旋多巴治疗帕金森病运动波动的临床经验。
Adv Neurol. 1990;53:383-6.
5
Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile.帕金森病的复杂性肌张力障碍:临床特征及其与血浆左旋多巴水平的关系。
Clin Neuropharmacol. 1990 Apr;13(2):164-70.
6
From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.从关期肌张力障碍到峰值剂量舞蹈症。不同丘脑底核活动的临床谱。
Brain. 1999 Jun;122 ( Pt 6):1133-46. doi: 10.1093/brain/122.6.1133.
7
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.肌张力障碍-帕金森综合征:左旋多巴和多巴胺激动剂的不同作用
Clin Neuropharmacol. 1986;9(3):298-302.
8
Dystonia in Parkinson's disease: clinical and pharmacological features.帕金森病中的肌张力障碍:临床和药理学特征
Ann Neurol. 1988 Jan;23(1):73-8. doi: 10.1002/ana.410230112.
9
Duodenal and gastric delivery of levodopa in parkinsonism.
Ann Neurol. 1988 Jun;23(6):589-95. doi: 10.1002/ana.410230611.
10
"Off" painful dystonia in Parkinson's disease treated with botulinum toxin.肉毒杆菌毒素治疗帕金森病中的“关闭期”疼痛性肌张力障碍
Mov Disord. 1995 May;10(3):333-6. doi: 10.1002/mds.870100317.

引用本文的文献

1
Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.人诱导多能干细胞衍生的中脑细胞球体在功能上整合到纹状体回路中,并在帕金森病小鼠模型中恢复运动功能。
Theranostics. 2023 Apr 29;13(8):2673-2692. doi: 10.7150/thno.80271. eCollection 2023.
2
Switching and Combining Device-Aided Therapies in Advanced Parkinson's Disease: A Double Centre Retrospective Study.晚期帕金森病中转换和联合使用器械辅助治疗:一项双中心回顾性研究
Brain Sci. 2022 Mar 2;12(3):343. doi: 10.3390/brainsci12030343.
3
Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum.
移植物诱导的运动障碍的解剖学:帕金森病纹状体中的神经回路重塑
Basal Ganglia. 2012 Mar 1;2(1):15-30. doi: 10.1016/j.baga.2012.01.002. Epub 2012 Feb 11.
4
Continuous levodopa for advanced Parkinson's disease.持续性左旋多巴治疗晚期帕金森病。
Neuropsychiatr Dis Treat. 2007 Jun;3(3):335-48.
5
Levodopa-induced dyskinesias and their management.左旋多巴诱发的异动症及其管理。
J Neurol. 2008 Aug;255 Suppl 4:32-41. doi: 10.1007/s00415-008-4006-5.
6
Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.帕金森病治疗中的药代动力学优化:最新进展
Clin Pharmacokinet. 2006;45(2):109-36. doi: 10.2165/00003088-200645020-00001.
7
Using liquid levodopa in the treatment of Parkinson's disease. A practical guide.使用左旋多巴治疗帕金森病。实用指南。
Drugs Aging. 1997 May;10(5):332-40. doi: 10.2165/00002512-199710050-00002.